VR Logo

Glenmark Life Sciences Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

48 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 2011

Chairman: Glenn Saldanha

Managing Director: Yasir Rawjee

Group: Glenmark

Listing: NSE: GLS, BSE: 543322

Headquarters: Solapur, Maharashtra

Website: www.glenmarklifesciences.com

Key Facts

Market cap: R 7,575.86 Cr

Revenue (TTM): R 1,885.17 Cr

Earnings (TTM): R 351.58 Cr

Cash: R 115.60 Cr

Total Debt: R 0.00 Cr

Promoters' ownership: --

Liquidity: Low

52 Week range: R 616.65 - 799.95

Face value: R2.00

Shares outstanding: 12,25,27,172

Stock Performance

Time Period Glenmark Life Sciences S&P BSE Healthcare S&P BSE Small Cap
YTD--15.6456.57
1 month-10.57-5.011.72
3 months---4.727.34
1 Year--27.4688.56
3 Years--19.9627.06
5 Years--8.9316.08
10 Years--15.4915.28
As on 22-Oct-2021